2025 Germany Biobanking Market Revenue Opportunities Report
Description
The 2025 Germany Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biobanking market in Germany are Merck KGaA, QIAGEN, Tecan Trading AG, and Thermo Fisher Scientific Inc. Merck KGaA, headquartered in Germany, offers comprehensive biobanking solutions including laboratory equipment, reagents, and services for sample collection and storage. QIAGEN, also German-based, specializes in molecular diagnostics and provides innovative technologies for nucleic acid purification and assay development. Tecan Trading AG, originally Swiss but with strong market presence in Germany, delivers automated liquid handling systems and robotic platforms for efficient biobank sample processing. Thermo Fisher Scientific, a US company, is a key player worldwide and in Germany, providing advanced biobanking devices and consumables for sample storage and management.
These companies dominate the German market due to their robust portfolios that address critical aspects of biobanking such as sample integrity, automation, and high-throughput processing. Merck KGaA leads with strong pharmaceutical and life sciences integration, while QIAGEN's molecular diagnostics complement biobanking needs for genomics research. Tecan supports automation, enhancing operational efficiency, and Thermo Fisher Scientific supplies comprehensive equipment and consumables. The German biobank market is growing rapidly with a CAGR of about 10%, supported by increasing precision medicine initiatives and regulatory frameworks such as GDPR influencing data management and sample handling practices.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biobanking market in Germany are Merck KGaA, QIAGEN, Tecan Trading AG, and Thermo Fisher Scientific Inc. Merck KGaA, headquartered in Germany, offers comprehensive biobanking solutions including laboratory equipment, reagents, and services for sample collection and storage. QIAGEN, also German-based, specializes in molecular diagnostics and provides innovative technologies for nucleic acid purification and assay development. Tecan Trading AG, originally Swiss but with strong market presence in Germany, delivers automated liquid handling systems and robotic platforms for efficient biobank sample processing. Thermo Fisher Scientific, a US company, is a key player worldwide and in Germany, providing advanced biobanking devices and consumables for sample storage and management.
These companies dominate the German market due to their robust portfolios that address critical aspects of biobanking such as sample integrity, automation, and high-throughput processing. Merck KGaA leads with strong pharmaceutical and life sciences integration, while QIAGEN's molecular diagnostics complement biobanking needs for genomics research. Tecan supports automation, enhancing operational efficiency, and Thermo Fisher Scientific supplies comprehensive equipment and consumables. The German biobank market is growing rapidly with a CAGR of about 10%, supported by increasing precision medicine initiatives and regulatory frameworks such as GDPR influencing data management and sample handling practices.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
